Development of a Therapeutic Endpoint in Pediatric Rheumatologic Conditions

Launched by CHILDREN'S NATIONAL RESEARCH INSTITUTE · Apr 2, 2021

Keywords

ClinConnect Summary

This clinical trial is focused on developing a new way to measure pain and treatment effects in children and teens with conditions like Juvenile Idiopathic Arthritis, Systemic Lupus Erythematosus, and Fibromyalgia. The goal is to create a more accurate method to assess pain, which could help doctors provide better and more personalized treatments, avoiding the usual trial-and-error process. The study will observe patients over one year, collecting data at regular doctor visits without changing their current treatments.

To participate in this study, individuals must be at least 5 years old and have a documented diagnosis of one of the targeted conditions. Unfortunately, those with certain eye diseases that could affect the study's measurements won't be able to join. Throughout the year, participants will have their pain responses recorded, helping researchers understand how effective standard treatments are for each condition. This is an important step towards improving care for young patients facing these challenging health issues.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• In order to be eligible for inclusion in the study, an individual must meet all of the following criteria:
• • Male or female ≥ 5 years of age at screening.
• • Documentation of a JIA, SLE or FM diagnosis as evidenced by history
• Exclusion Criteria:
• Any individual who meets any of the following criteria will be excluded from participation in this study:
• • • Documented history of eye disease precluding pupillometry